Gankyrin activates IL-8 to promote hepatic metastasis of colorectal cancer

Cancer Research

Volumn 73, Issue 14, 2013, Pages 4548-4558

  Bai, Zhaofang ^a   Tai, Yanhong ^b   Li, Weihua ^c   Zhen, Cheng ^a   Gu, Weiting ^c   Jian, Zhao ^a   Wang, Qianyi ^a   Lin, Jieru E ^d   Zhao, Qing ^a   Gong, Weili ^a   Liang, Bing ^a   Wang, Chenguang ^c   Zhou, Tao ^a  

^a NATIONAL CENTER OF BIOMEDICAL ANALYSIS   (China)

^b 90th Hospital of Jinan   (China)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; CYCLIN D1; INTERLEUKIN 8;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; CANCER MORTALITY; CELL CULTURE; CELL CYCLE; CELL DEATH; CELL INTERACTION; CELL INVASION; CELL MIGRATION; COLORECTAL CANCER; CONTROLLED STUDY; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; GENE CONTROL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIVER METASTASIS; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR GROWTH;

3T3 CELLS; ANIMALS; CELL LINE; CELL MOVEMENT; COLORECTAL NEOPLASMS; CYCLIN D1; HEK293 CELLS; HUMANS; INTERLEUKIN-8; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION;

EID: 84880881002     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-4586     Document Type: Article

References (52)

1. Hori T, Kato S, Saeki M, DeMartino GN, Slaughter CA, Takeuchi J, et al. cDNA cloning and functional analysis of p28 (Nas6p) and p40.5 (Nas7p), two novel regulatory subunits of the 26S proteasome. Gene 1998;216:113-22.
2. Chen Y, Li HH, Fu J, Wang XF, Ren YB, Dong LW, et al. Oncoprotein p28 GANK binds to RelA and retains NF-kappaB in the cytoplasm through nuclear export. Cell Res 2007;17:1020-9.
3. Li J, Tsai MD. Novel insights into the INK4-CDK4/6-Rb pathway: counter action of gankyrin against INK4 proteins regulates the CDK4-mediated phosphorylation of Rb. Biochemistry 2002;41: 3977-83.
4. Higashitsuji H, Itoh K, Nagao T, Dawson S, Nonoguchi K, Kido T, et al. Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas. Nat Med 2000; 6:96-9.
5. Umemura A, Itoh Y, Itoh K, Yamaguchi K, Nakajima T, Higashitsuji H, et al. Association of gankyrin protein expression with early clinical stages and insulin-like growth factor-binding protein 5 expression in human hepatocellular carcinoma. Hepatology 2008;47:493-502.
6. Ortiz CM, Ito T, Tanaka E, Tsunoda S, Nagayama S, Sakai Y, et al. Gankyrin oncoprotein overexpression as a critical factor for tumor growth in human esophageal squamous cell carcinoma and its clinical significance. Int J Cancer 2008;122:325-32.
7. Tang S, Yang G, Meng Y, Du R, Li X, Fan R, et al. Overexpression of a novel gene gankyrin correlates with the malignant phenotype of colorectal cancer. Cancer Biol Ther 2010;9:88-95.
8. Li J, Knobloch TJ, Kresty LA, Zhang Z, Lang JC, Schuller DE, et al. Gankyrin, a biomarker for epithelial carcinogenesis, is overexpressed in human oral cancer. Anticancer Res 2011;31:2683-92.
9. Sun W, Ding J, Wu K, Ning BF, Wen W, Sun HY, et al. Gankyrinmediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells. Hepatology 2011;54:1259-72.
10. Zhen C, Chen L, Zhao Q, Liang B, Gu YX, Bai ZF, et al. Gankyrin promotes breast cancer cell metastasis by regulating Rac1 activity. Oncogene 2012 Aug 13. [Epub ahead of print].
11. Mayer RJ, Fujita J. Gankyrin, the 26 S proteasome, the cell cycle and cancer. Biochem Soc Trans 2006;34:746-8.
12. Dawson S, Higashitsuji H, Wilkinson AJ, Fujita J, Mayer RJ. Gankyrin: a new oncoprotein and regulator of pRb and p53. Trends Cell Biol 2006;16:229-33.
13. Lozano G, Zambetti GP. Gankyrin: an intriguing name for a novel regulator of p53 and RB. Cancer Cell 2005;8:3-4.
14. Higashitsuji H, Itoh K, Sakurai T, Nagao T, Sumitomo Y, Masuda T, et al. The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53. Cancer Cell 2005;8:75-87.
15. Wang GL, Shi X, Haefliger S, Jin J, Major A, Iakova P, et al. Elimination of C/EBPalpha through the ubiquitin-proteasome system promotes the development of liver cancer in mice. J Clin Invest 2010;120: 2549-62.
16. Man JH, Liang B, Gu YX, Zhou T, Li AL, Li T, et al. Gankyrin plays an essential role in Ras-induced tumorigenesis through regulation of the RhoA/ROCK pathway in mammalian cells. J Clin Invest 2010;120: 2829-41.
17. Dong LW, Yang GZ, Pan YF, Chen Y, Tan YX, Dai RY, et al. The oncoprotein p28GANK establishes a positive feedback loop in betacatenin signaling. Cell Res 2011;21:1248-61.
18. Fu J, Chen Y, Cao J, Luo T, Qian YW, Yang W, et al. p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1alpha pathways. Hepatology 2011;53:181-92.
19. Zhang J, Yang Y, Zhang Z, He Y, Liu Z, Yu Y, et al. Gankyrin plays an essential role in estrogen-driven and GPR30-mediated endometrial carcinoma cell proliferation via the PTEN/PI3K/AKT signaling pathway. Cancer Lett. 2012 Nov 8. [Epub ahead of print].
20. Bengmark S, Hafstrom L. The natural history of primary and secondary malignant tumors of the liver. II. The prognosis for patients with hepatic metastases from gastric carcinoma verified by laparotomy and postmortem examination. Digestion 1969;2:179-86.
21. Bentrem DJ, Dematteo RP, Blumgart LH. Surgical therapy for metastatic disease to the liver. Annu Rev Med 2005;56:139-56.
22. Kawada K, Hasegawa S, Murakami T, Itatani Y, Hosogi H, Sonoshita M, et al. Molecular mechanisms of liver metastasis. Int J Clin Oncol 2011;16:464-72.
23. Suzuki H, Masuda N, Shimura T, Araki K, Kobayashi T, Tsutsumi S, et al. Nuclear beta-catenin expression at the invasive front and in the vessels predicts liver metastasis in colorectal carcinoma. Anticancer Res 2008;28:1821-30.
24. Haraguchi M, Komuta K, Akashi A, Matsuzaki S, Furui J, Kanematsu T. Elevated IL-8 levels in the drainage vein of resectable Dukes' C colorectal cancer indicate high risk for developing hepatic metastasis. Oncol Rep 2002;9:159-65.
25. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A 1999;96:5522-7.
26. MacManus CF, Pettigrew J, Seaton A, Wilson C, Maxwell PJ, Berlingeri S, et al. Interleukin-8 signaling promotes translational regulation of cyclin D in androgen-independent prostate cancer cells. Mol Cancer Res 2007;5:737-48.
27. Saridaki Z, Papadatos-Pastos D, Tzardi M, Mavroudis D, Bairaktari E, Arvanity H, et al. BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients' outcome. Br J Cancer 2010;102:1762-8.
28. Pan X, Zhou T, Tai YH, Wang C, Zhao J, Cao Y, et al. Elevated expression of CUEDC2 protein confers endocrine resistance in breast cancer. Nat Med 2011;17:708-14.
29. Budwit-Novotny DA, McCarty KS, Cox EB, Soper JT, Mutch DG, Creasman WT, et al. Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res 1986;46:5419-25.
30. Wang C, Pattabiraman N, Zhou JN, Fu M, Sakamaki T, Albanese C, et al. Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation. Mol Cell Biol 2003;23: 6159-73.
31. Fox BA, Spiess PJ, Kasid A, Puri R, Mule JJ, Weber JS, et al. In vitro and in vivo antitumor properties of a T-cell clone generated from murine tumor-infiltrating lymphocytes. J Biol Response Mod 1990;9:499-511.
32. Snook AE, Stafford BJ, Li P, Tan G, Huang L, Birbe R, et al. Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity. J Natl Cancer Inst 2008; 100:950-61.
33. Luo X, Chen L, Dai J, Gao Y, Wang H, Wang N, et al. Gankyrin gene deletion followed by proteomic analysis: insight into the roles of Gankyrin in tumorigenesis and metastasis. BMC Med Genomics 2012;5:36.
34. Leach FS, Elledge SJ, Sherr CJ, Willson JK, Markowitz S, Kinzler KW, et al. Amplification of cyclin genes in colorectal carcinomas. Cancer Res 1993;53:1986-9.
35. Bartkova J, Lukas J, Strauss M, Bartek J. The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas. Int J Cancer 1994;58:568-73.
36. Arber N, Hibshoosh H, Moss SF, Sutter T, Zhang Y, Begg M, et al. Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology 1996;110:669-74.
37. Bahnassy AA, Zekri AR, El-Houssini S, El-ShehabyAM, Mahmoud MR, Abdallah S, et al. Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients. BMC Gastroenterology. 2004; 4:22.
38. Jin J, Wang GL, Iakova P, Shi X, Haefliger S, Finegold M, et al. Epigenetic changes play critical role in age-associated dysfunctions of the liver. Aging Cell 2010;9:895-910.
39. Iwai A, Marusawa H, Kiuchi T, Higashitsuji H, Tanaka K, Fujita J, et al. Role of a novel oncogenic protein, gankyrin, in hepatocyte proliferation. J Gastroenterol 2003;38:751-8.
40. Meng Y, He L, Guo X, Tang S, Zhao X, Du R, et al. Gankyrin promotes the proliferation of human pancreatic cancer. Cancer Lett 2010; 297:9-17.
41. Mahajan A, Guo Y, Yuan C, Weghorst CM, Tsai MD, Li J. Dissection of protein-protein interaction and CDK4 inhibition in the oncogenic versus tumor suppressing functions of gankyrin and P16. J Mol Biol 2007;373:990-1005.
42. Qiu W, Wu J, Walsh EM, Zhang Y, Chen CY, Fujita J, et al. Retinoblastoma protein modulates gankyrin-MDM2 in regulation of p53 stability and chemosensitivity in cancer cells. Oncogene 2008;27: 4034-43.
43. Jiang Y, Iakova P, Jin J, Sullivan E, Sharin V, Hong IH, et al. Farnesoid X receptor inhibits gankyrin in mouse livers and prevents development of liver cancer. Hepatology 2012;57:1098-106.
44. Higashitsuji H, Liu Y, Masuda T, Fujita T, Abdel-Aziz HI, Kongkham S, et al. The oncoprotein gankyrin interacts with RelA and suppresses NFkappaB activity. Biochem Biophys Res Commun 2007;363:879-84.
45. Qian YW, Chen Y, Yang W, Fu J, Cao J, Ren YB, et al. p28(GANK) prevents degradation of Oct4 and promotes expansion of tumorinitiating cells in hepatocarcinogenesis. Gastroenterology 2012;142: 1547-58.
46. Her GM, Hsu CC, Hong JR, Lai CY, Hsu MC, Pang HW, et al. Overexpression of gankyrin induces liver steatosis in zebrafish (Danio rerio). Biochim Biophys Acta 2011;1811:536-48.
47. Fu XY, Wang HY, Tan L, Liu SQ, Cao HF, Wu MC. Overexpression of p28/gankyrin in human hepatocellular carcinoma and its clinical significance. World J Gastroenterol 2002;8:638-43.
48. Nagao T, Higashitsuji H, Nonoguchi K, Sakurai T, Dawson S, Mayer RJ, et al. MAGE-A4 interacts with the liver oncoprotein gankyrin and suppresses its tumorigenic activity. J Biol Chem 2003;278: 10668-74.
49. Neumeister P, Pixley FJ, Xiong Y, Xie H, WuK, Ashton A, et al. Cyclin D1 governs adhesion and motility of macrophages. Mol Biol Cell 2003;14:2005-15.
50. Fu M, Wang C, Li Z, Sakamaki T, Pestell RG. Minireview: Cyclin D1: normal and abnormal functions. Endocrinology 2004;145:5439-47.
51. Arber N, Doki Y, Han EK, Sgambato A, Zhou P, Kim NH, et al. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. Cancer Res 1997;57:1569-74.
52. Hulit J, Wang C, Li Z, Albanese C, Rao M, Di Vizio D, et al. Cyclin D1 genetic heterozygosity regulates colonic epithelial cell differentiation and tumor number in ApcMin mice. Mol Cell Biol 2004;24: 7598-611.